Tanya M Laidlaw MD
Assistant Professor in Medicine, Harvard Medical School Director of Translational Research in Allergy, Brigham and Women's Hospital
Join to View Full Profile
850 Boylston StreetBrigham and Women's HospitalChestnut Hill, MA 02467
Phone+1 617-732-9850
Dr. Laidlaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
Brigham and Women's HospitalFellowship, Allergy and Immunology, 2006 - 2009
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2003 - 2006
University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2026
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
Clinical Trials
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) Start of enrollment: 2012 Aug 31
- High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) Start of enrollment: 2014 Mar 01
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban Start of enrollment: 2018 Apr 26
Publications & Presentations
PubMed
- Characteristics associated with rapid chronic rhinosinusitis with nasal polyp recurrence following endoscopic sinus surgery in NSAID-exacerbated respiratory disease.Tiffany Dharia, Joel Swirnoff, Tanya M Laidlaw, Kathleen M Buchheit
The Journal of Allergy and Clinical Immunology. Global. 2026-05-01 - Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study.Jorge F Maspero, Ian D Pavord, Michael E Wechsler, William Busse, Tanya M Laidlaw
The Lancet. Respiratory Medicine. 2026-05-01 - Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusit...Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, Claire Hopkins, Anju T Peters
International Forum of Allergy & Rhinology. 2026-05-01
Journal Articles
- Original Article A One-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory DiseaseTanya Laidlaw, Geneva A DeGregorio, Katherine N Cahill, ScienceDirect
- Allergic Inflammatory Memory in Human Respiratory Epithelial Progenitor CellsNora A Barrett, Tanya M Laidlaw, Joshua A Boyce, Neil Bhattacharyya, Kathleen M Buchheit, Katherine N Cahill, Nature
Authored Content
- Clinical Communications Accidental Ingestion of Aspirin and Non-Steroidal Anti-Inflammatory Drugs Is Common in Patients with Aspirin-Exacerbated Respiratory DiseaseNovember 2018
Press Mentions
New Asthma Research Effort Aims for Better Understanding, TreatmentsJanuary 8th, 2025- How Do AERD Patients' Self-Reports Compare with Objective Tests?February 9th, 2022
- Allergies or COVID? One Boston Expert with How to Tell:September 2nd, 2021
Grant Support
- Patient-Oriented Research Mentorship and Training in Upper Airway Allergic and Inflammatory DiseasesBRIGHAM AND WOMEN'S HOSPITAL2023–2028
Professional Memberships
- Member
External Links
- Samter's Triad/AERDhttp://aerd.partners.org
- BWH AERDhttp://www.brighamandwomens.org/Departments_and_Services/medicine/services/rheumatology/Services/aspirin-exacerbated-respiratory-disease.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
